MycoBiomDB – Record Details (MyCo_1947)

Biomarker Record Details

Database ID: MyCo_1947
DB IDMyCo_1947
TitleIncreased serum soluble CD14, ICAM-1 and E-selectin correlate with disease activity and prognosis in systemic lupus erythematosus
Year2000
PMID11035437
Fungal Diseases involvedSepsis
Associated Medical ConditionSystemic lupus erythematosus (SLE) and Primary Sjo Ègren's syndrome (pSS)
GenusCandida
Speciesalbicans
OrganismCandida albicans
Ethical StatementNone
Site of InfectionNone
Opportunistic invasiveNone
Sample typeBody fluid
Sample sourceSerum
Host GroupHuman
Host Common nameHuman
Host Scientific nameHomo sapiens
Biomarker NamesE-selectin
Biomarker Full NameSoluble E-selectin
Biomarker TypePrognostic
BiomoleculeProtein
Geographical LocationGermany
CohortSera from the following patient groups were analyzed: 33 patients with SLE ful®lling the 1982 revised ACR criteria, 11 patients with primary Sjo Ègren's syndrome (pSS) diagnosed according to Vitali et al, 35 patients admitted to an intensive care unit because of an underlying infectious disease.
Cohort No.33
Age GroupNone
P Valuep<0.001
SensitivityNone
SpecificityNone
Positive Predictive ValueNone
MICNone
Fold ChangeNone
PathwayNone
Disease Introduction MechanismSystemic lupus erythematosus (SLE) and primary Sjo Ègren's syndrome (pSS) represent distinct, but in some instances clinically and pathogenically overlapping connective tissue diseases.1,2 Both diseases are characterized by marked activation of lymphocytes including autoreactive T and B cells and the production of a variety of autoantibodies.3 In both entities, organ involvement and prognosis are frequently dependent on the degree of systemic vasculitis.
TechniqueELISA
Analysis MethodELISA Based
ELISA kitsSandwich ELISA (IBL,Hamburg Germany)
Assay DataNone
Validation Techniques usedELISA
Up Regulation Down RegulationIncrease
Sequence DataNone
External LinkNone